(NEW YORK)Dutch biotechnology company Crucell NV said Friday it received a contract worth up to $70 million from the National Institutes of Allergy and Infectious Diseases to develop a vacci...READ MORE
(NEW YORK)Dutch biotechnology company Crucell NV said Tuesday it will move production of its anti-diarrhea drug Dukoral out of Sweden in order to save money. The Leiden-based company said it...READ MORE
Among the earnings stories for Tuesday, Aug. 12, from AP Financial News: NEW YORK (AP)--Shares of Bway Holding Co. hit a 52-week high on Tuesday, after the supplier of metal and pl...READ MORE
(NEW YORK)Dutch biotechnology company Crucell NV said Tuesday its second-quarter loss narrowed on higher sales of pediatric vaccines and increased licensing fees.READ MORE
Among the stock activity stories for Wednesday, June 25, from AP Financial News: NEW YORK (AP)--Shares of Crucell N.V. jumped Wednesday after the Dutch biotechnology company said A...READ MORE
(NEW YORK)Shares of Crucell N.V. jumped Wednesday after the Dutch biotechnology company said Avid BioServices Inc. is the first preapproved U.S. supplier for materials related to its new dru...READ MORE